Skip to content
Advertisement

FILE - An arrangement of Oxycodone pills sit next to a bottle in New York on Aug. 29, 2018. A long-awaited review of prescription opioid medications, including their risks and contribution to the U.S. overdose epidemic, is still underway at the Food and Drug Administration, the agency's commissioner said Tuesday, Aug. 30, 2022. (AP Photo/Mark Lennihan, File)

FILE - An arrangement of Oxycodone pills sit next to a bottle in New York on Aug. 29, 2018. A long-awaited review of prescription opioid medications, including their risks and contribution to the U.S. overdose epidemic, is still underway at the Food and Drug Administration, the agency's commissioner said Tuesday, Aug. 30, 2022. (AP Photo/Mark Lennihan, File)

Featured Photo Galleries